Black JD - Search Results

1

Epidermal growth factor receptor expression correlates with histologic grade in resected esophageal adenocarcinoma.

Wilkinson NW, Black JD, Roukhadze E, Driscoll D, Smiley S, Hoshi H, Geradts J, Javle M, Brattain M. Wilkinson NW, et al. Among authors: black jd. J Gastrointest Surg. 2004 May-Jun;8(4):448-53. doi: 10.1016/j.gassur.2004.01.006. J Gastrointest Surg. 2004. PMID: 15120370

2

Epidermal growth factor receptor-directed therapy in esophageal cancer.

Pande AU, Iyer RV, Rani A, Maddipatla S, Yang GY, Nwogu CE, Black JD, Levea CM, Javle MM. Pande AU, et al. Among authors: black jd. Oncology. 2007;73(5-6):281-9. doi: 10.1159/000132393. Epub 2008 May 14. Oncology. 2007. PMID: 18477853 Review.

3

Intestinal trefoil factor (TFF-3) and extracellular signal-regulated kinase (ERK) in cholangiocarcinoma.

Ailawadhi S, Nagase H, Khoury T, Yu J, Tan D, Black J, Brattain M, Javle M. Ailawadhi S, et al. Hepatogastroenterology. 2007 Jul-Aug;54(77):1339-44. Hepatogastroenterology. 2007. PMID: 17708250

4

Activated Akt and Erk expression and survival after surgery in pancreatic carcinoma.

Chadha KS, Khoury T, Yu J, Black JD, Gibbs JF, Kuvshinoff BW, Tan D, Brattain MG, Javle MM. Chadha KS, et al. Among authors: black jd. Ann Surg Oncol. 2006 Jul;13(7):933-9. doi: 10.1245/ASO.2006.07.011. Epub 2006 May 22. Ann Surg Oncol. 2006. PMID: 16788754

5

Akt expression may predict favorable prognosis in cholangiocarcinoma.

Javle MM, Yu J, Khoury T, Chadha KS, Iyer RV, Foster J, Kuvshinoff BW, Gibbs JF, Geradts J, Black JD, Brattain MG. Javle MM, et al. Among authors: black jd. J Gastroenterol Hepatol. 2006 Nov;21(11):1744-51. doi: 10.1111/j.1440-1746.2006.04373.x. J Gastroenterol Hepatol. 2006. PMID: 16984600

6

Pilot study of gefitinib, oxaliplatin, and radiotherapy for esophageal adenocarcinoma: tissue effect predicts clinical response.

Javle M, Pande A, Iyer R, Yang G, LeVea C, Wilding G, Black J, Nava H, Nwogu C. Javle M, et al. Am J Clin Oncol. 2008 Aug;31(4):329-34. doi: 10.1097/COC.0b013e318161dc04. Am J Clin Oncol. 2008. PMID: 18845990 Clinical Trial.

7

ErbB family targeting.

Black JD, Brattain MG, Krishnamurthi SA, Dawson DM, Willson JK. Black JD, et al. Curr Opin Investig Drugs. 2003 Dec;4(12):1451-4. Curr Opin Investig Drugs. 2003. PMID: 14763131 Review.

8

A phase I pharmacokinetic and pharmacodynamic study of intravenous calcitriol in combination with oral gefitinib in patients with advanced solid tumors.

Fakih MG, Trump DL, Muindi JR, Black JD, Bernardi RJ, Creaven PJ, Schwartz J, Brattain MG, Hutson A, French R, Johnson CS. Fakih MG, et al. Among authors: black jd. Clin Cancer Res. 2007 Feb 15;13(4):1216-23. doi: 10.1158/1078-0432.CCR-06-1165. Clin Cancer Res. 2007. PMID: 17317832 Clinical Trial.

9

Epithelial-mesenchymal transition (EMT) and activated extracellular signal-regulated kinase (p-Erk) in surgically resected pancreatic cancer.

Javle MM, Gibbs JF, Iwata KK, Pak Y, Rutledge P, Yu J, Black JD, Tan D, Khoury T. Javle MM, et al. Among authors: black jd. Ann Surg Oncol. 2007 Dec;14(12):3527-33. doi: 10.1245/s10434-007-9540-3. Epub 2007 Sep 19. Ann Surg Oncol. 2007. PMID: 17879119

10

Correlation of PRL3 expression with colorectal cancer progression.

Leiphrakpam PD, Lazenby AJ, Smith LM, Brattain MG, Black JD, Wang J, Are C. Leiphrakpam PD, et al. Among authors: black jd. J Surg Oncol. 2021 Jan;123(1):42-51. doi: 10.1002/jso.26253. Epub 2020 Nov 12. J Surg Oncol. 2021. PMID: 33179291 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

162 results

Search Page

Filters